Interpace Biosciences
IDXG
#10516
Rank
NZ$65.22 M
Marketcap
NZ$11.05
Share price
-11.43%
Change (1 day)
534.54%
Change (1 year)

Earnings for Interpace Biosciences (IDXG)

Earnings in 2026 (TTM): NZ$6.99 Million

According to Interpace Biosciences's latest financial reports the company's current earnings are NZ$36.14 Million. In 2025 the company made an earning of NZ$7.02 Million a decrease over its 2024 earnings that were of NZ$15.36 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Interpace Biosciences from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$6.99 M-0.43%
2025 NZ$7.02 M-54.26%
2024 NZ$15.36 M303.23%
2023 NZ$3.81 M-144.63%
2022 -NZ$8.54 Million-60.98%
2021 -NZ$21.89 Million-52.04%
2020 -NZ$45.63 Million-2.68%
2019 -NZ$46.89 Million121.84%
2018 -NZ$21.14 Million-6.07%
2017 -NZ$22.51 Million96.31%
2016 -NZ$11.47 Million-86.7%
2015 -NZ$86.2 Million382.48%
2014 -NZ$17.87 Million134.35%
2013 -NZ$7.63 Million323.89%
2012 -NZ$1.8 Million-79.01%
2011 -NZ$8.57 Million29.08%
2010 -NZ$6.64 Million-82.57%
2009 -NZ$38.09 Million-39.28%
2008 -NZ$62.73 Million146.45%
2007 -NZ$25.46 Million-269.18%
2006 NZ$15.04 M-131.08%
2005 -NZ$48.41 Million-177.16%
2004 NZ$62.72 M78.33%
2003 NZ$35.17 M-142.02%
2002 -NZ$83.71 Million-469.63%
2001 NZ$22.64 M-68.92%
2000 NZ$72.86 M140.45%
1999 NZ$30.3 M
1997 NZ$4.27 M